{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:58:43Z","timestamp":1773287923508,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the late autumn of 2019, a\u00a0new potentially lethal human coronavirus designated severe acute respiratory syndrome coronavirus\u00a02 (SARS-CoV-2) emerged in Wuhan, China. The pandemic spread of this zoonotic virus has created a\u00a0global health emergency and an unprecedented socioeconomic crisis. The severity of coronavirus disease 2019 (COVID-19), the illness caused by SARS-CoV\u20112, is highly variable. Most patients (~85%) develop no or mild symptoms, while others become seriously ill, some succumbing to disease-related complications. In this review, the SARS-CoV\u20112 life cycle, its transmission and the clinical and immunological features of COVID-19 are described. In addition, an overview is presented of the virological assays for detecting ongoing SARS-CoV\u20112 infections and the serological tests for SARS-CoV-2-specific antibody detection. Also discussed are the different approaches to developing a\u00a0COVID-19 vaccine and the perspectives of treating COVID-19 with antiviral drugs, immunomodulatory agents and anticoagulants\/antithrombotics. Finally, the cardiovascular manifestations of COVID-19 are briefly touched upon. While there is still much to learn about SARS-CoV\u20112, the tremendous recent advances in biomedical technology and knowledge and the huge amount of research into COVID-19 raise the hope that a\u00a0remedy for this disease will soon be found. COVID-19 will nonetheless have a\u00a0lasting impact on human society.<\/jats:p>","DOI":"10.1007\/s12471-020-01475-1","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T08:02:45Z","timestamp":1594800165000},"page":"366-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["SARS-CoV-2\/COVID-19: a\u00a0primer for cardiologists"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4787-7155","authenticated-orcid":false,"given":"A. A. F.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bmj.1.5448.1467","volume":"1","author":"DA Tyrrell","year":"1965","unstructured":"Tyrrell\u00a0DA, Bynoe\u00a0ML. Cultivation of a\u00a0novel type of common-cold virus in organ cultures. Br Med\u00a0J. 1965;1:1467\u201370.","journal-title":"Br Med J"},{"key":"1475_CR2","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","volume":"24","author":"JS Kahn","year":"2005","unstructured":"Kahn\u00a0JS, McIntosh\u00a0K. History and recent advances in coronavirus discovery. Pediatr Infect Dis\u00a0J. 2005;24:S223\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"1475_CR3","doi-asserted-by":"crossref","first-page":"27142","DOI":"10.1073\/pnas.1911083116","volume":"116","author":"S Nickbakhsh","year":"2019","unstructured":"Nickbakhsh\u00a0S, Mair\u00a0C, Matthews\u00a0L, et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S\u00a0A. 2019;116:27142\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1475_CR4","doi-asserted-by":"crossref","first-page":"e1008536","DOI":"10.1371\/journal.ppat.1008536","volume":"16","author":"D Tang","year":"2020","unstructured":"Tang\u00a0D, Comish\u00a0P, Kang\u00a0R. The hallmarks of COVID-19 disease. PLoS Pathog. 2020;16:e1008536.","journal-title":"PLoS Pathog"},{"key":"1475_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan\u00a0JF, Yuan\u00a0S, Kok\u00a0KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a\u00a0study of a\u00a0family cluster. Lancet. 2020;395:514\u201323.","journal-title":"Lancet"},{"key":"1475_CR6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu\u00a0N, Zhang\u00a0D, Wang\u00a0W, et\u00a0al. A novel coronavirus from patients with pneumonia in China, 2019. N\u00a0Engl J Med. 2020;382:727\u201333.","journal-title":"N Engl J Med"},{"key":"1475_CR7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses.","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses.. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV\u20112. Nat Rev Microbiol. 2020;5:536\u201344.","journal-title":"Nat. Rev. Microbiol."},{"key":"1475_CR8","doi-asserted-by":"crossref","first-page":"e1008421","DOI":"10.1371\/journal.ppat.1008421","volume":"16","author":"P Liu","year":"2020","unstructured":"Liu\u00a0P, Jiang\u00a0JZ, Wan\u00a0XF, et al. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog. 2020;16:e1008421.","journal-title":"PLoS Pathog"},{"key":"1475_CR9","doi-asserted-by":"crossref","first-page":"e1008271","DOI":"10.1371\/journal.pgen.1008271","volume":"15","author":"E Domingo","year":"2019","unstructured":"Domingo\u00a0E, Perales\u00a0C. Viral quasispecies. PLoS Genet. 2019;15:e1008271.","journal-title":"PLoS Genet"},{"key":"1475_CR10","first-page":"806","volume-title":"Virus taxonomy. Ninth report of the international committee on taxonomy of viruses","author":"RJ de Groot","year":"2012","unstructured":"de Groot\u00a0RJ, Baker\u00a0SC, Baric\u00a0R, et\u00a0al. Family coronaviridae. In: King\u00a0AMQ, Adams\u00a0MJ, Carstens\u00a0EB, Lefkowitz\u00a0EJ, editors. Virus taxonomy. Ninth report of the international committee on taxonomy of viruses. Amsterdam: Elsevier; 2012. pp.\u00a0806\u201328."},{"key":"1475_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann\u00a0M, Kleine-Weber\u00a0H, Schroeder\u00a0S, et al. SARS-CoV\u20112 cell entry depends on ACE2 and TMPRSS2 and is blocked by a\u00a0clinically proven protease inhibitor. Cell. 2020;181:271\u201380.","journal-title":"Cell"},{"key":"1475_CR12","doi-asserted-by":"crossref","first-page":"104792","DOI":"10.1016\/j.antiviral.2020.104792","volume":"178","author":"T Tang","year":"2020","unstructured":"Tang\u00a0T, Bidon\u00a0M, Jaimes\u00a0JA, et\u00a0al. Coronavirus membrane fusion mechanism offers a\u00a0potential target for antiviral development. Antiviral Res. 2020;178:104792.","journal-title":"Antiviral Res"},{"key":"1475_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.14.988345","volume-title":"SARS-CoV-2 invades host cells via a\u00a0novel route: CD147-spike protein","author":"K Wang","year":"2020","unstructured":"Wang\u00a0K, Chen\u00a0W, Zhou\u00a0Y\u2011S, et al. SARS-CoV\u20112 invades host cells via a\u00a0novel route: CD147-spike protein. 2020. https:\/\/doi.org\/10.1101\/2020.03.14.988345. bioRxiv 2020.03.14.988345."},{"key":"1475_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.virusres.2017.01.023","volume":"234","author":"CC Posthuma","year":"2017","unstructured":"Posthuma\u00a0CC, Te Velthuis\u00a0AJW, Snijder\u00a0EJ. Nidovirus RNA polymerases: complex enzymes handling exceptional RNA genomes. Virus Res. 2017;234:58\u201373.","journal-title":"Virus Res"},{"key":"1475_CR15","first-page":"1","volume":"419","author":"AH de Wilde","year":"2018","unstructured":"de Wilde\u00a0AH, Snijder\u00a0EJ, Kikkert\u00a0M, et\u00a0al. Host factors in coronavirus replication. Curr Top Microbiol Immunol. 2018;419:1\u201342.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1475_CR16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"D Kim","year":"2020","unstructured":"Kim\u00a0D, Lee\u00a0JY, Yang\u00a0JS, et al. The architecture of SARS-CoV\u20112 transcriptome. Cell. 2020;181:914\u201321.","journal-title":"Cell"},{"key":"1475_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2014.06.013","volume":"109","author":"DX Liu","year":"2014","unstructured":"Liu\u00a0DX, Fung\u00a0TS, Chong\u00a0KK, et al. Accessory proteins of SARS-CoV and other coronaviruses. Antiviral Res. 2014;109:97\u2013109.","journal-title":"Antiviral Res"},{"key":"1475_CR18","doi-asserted-by":"crossref","first-page":"2000256","DOI":"10.2807\/1560-7917.ES.2020.25.12.2000256","volume":"25","author":"TW Russell","year":"2020","unstructured":"Russell\u00a0TW, Hellewell\u00a0J, Jarvis\u00a0CI, et al. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the diamond princess cruise ship, february 2020. Euro Surveill. 2020;25:2000256.","journal-title":"Euro Surveill"},{"key":"1475_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.06.20092999","volume-title":"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients","author":"The OpenSAFELY Collaborative","year":"2020","unstructured":"The OpenSAFELY Collaborative. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. 2020. https:\/\/doi.org\/10.1101\/2020.05.06.20092999. medRxiv 2020.05.06.20092999."},{"key":"1475_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13054-020-02902-w","volume":"24","author":"G Deng","year":"2020","unstructured":"Deng\u00a0G, Yin\u00a0M, Chen\u00a0X, Zeng\u00a0F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24:179.","journal-title":"Crit Care"},{"key":"1475_CR21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020283","author":"D Ellinghaus","year":"2020","unstructured":"Ellinghaus\u00a0D, Degenhardt\u00a0F, Bujanda\u00a0L, et al. Genomewide association study of severe COVID-19 with respiratory failure. N\u00a0Engl J Med. 2020; https:\/\/doi.org\/10.1056\/NEJMoa2020283.","journal-title":"N Engl J Med"},{"key":"1475_CR22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li\u00a0Q, Guan\u00a0X, Wu\u00a0P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N\u00a0Engl J Med. 2020;382:1199\u2013207.","journal-title":"N Engl J Med"},{"key":"1475_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He\u00a0X, Lau\u00a0EHY, Wu\u00a0P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26:672\u20135.","journal-title":"Nat Med"},{"key":"1475_CR24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijid.2020.04.057","volume":"95","author":"ES Amirian","year":"2020","unstructured":"Amirian\u00a0ES. Potential fecal transmission of SARS-CoV-2: current evidence and implications for public health. Int J Infect Dis. 2020;95:363\u201370.","journal-title":"Int J Infect Dis"},{"key":"1475_CR25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.052","author":"S Ding","year":"2020","unstructured":"Ding\u00a0S, Liang\u00a0TJ. Is SARS-CoV\u20112 also an enteric pathogen with potential fecal-oral transmission: a\u00a0COVID-19 virological and clinical review. Gastroenterology. 2020; https:\/\/doi.org\/10.1053\/j.gastro.2020.04.052.","journal-title":"Gastroenterology"},{"key":"1475_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1669","author":"MM Lamers","year":"2020","unstructured":"Lamers\u00a0MM, Beumer\u00a0J, van der Vaart\u00a0J, et al. SARS-CoV\u20112 productively infects human gut enterocytes. Science. 2020; https:\/\/doi.org\/10.1126\/science.abc1669.","journal-title":"Science"},{"key":"1475_CR27","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","volume":"158","author":"F Xiao","year":"2020","unstructured":"Xiao\u00a0F, Tang\u00a0M, Zheng\u00a0X, et al. Evidence for gastrointestinal infection of SARS-CoV\u20112. Gastroenterology. 2020;158:1831\u20133.","journal-title":"Gastroenterology"},{"key":"1475_CR28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.abb7015","volume":"368","author":"J Shi","year":"2020","unstructured":"Shi\u00a0J, Wen\u00a0Z, Zhong\u00a0G, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368:1016\u201320.","journal-title":"Science"},{"key":"1475_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215091","author":"AJ Ing","year":"2020","unstructured":"Ing\u00a0AJ, Cocks\u00a0C, Green\u00a0JP. COVID-19: in the footsteps of Ernest Shackleton. Thorax. 2020; https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215091.","journal-title":"Thorax"},{"key":"1475_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","author":"Z Wu","year":"2020","unstructured":"Wu\u00a0Z, McGoogan\u00a0JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a\u00a0report of 72\u202f314 cases from the Chinese center for disease control and prevention. JAMA. 2020; https:\/\/doi.org\/10.1001\/jama.2020.2648.","journal-title":"JAMA"},{"key":"1475_CR31","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/eurheartj\/ehaa462","volume":"41","author":"JM Peric\u00e0s","year":"2020","unstructured":"Peric\u00e0s\u00a0JM, Hernandez-Meneses\u00a0M, Sheahan\u00a0TP, et al. COVID-19: from epidemiology to treatment. Eur Heart\u00a0J. 2020;41:2092\u2013112.","journal-title":"Eur Heart J"},{"key":"1475_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2112","author":"A Pormohammad","year":"2020","unstructured":"Pormohammad\u00a0A, Ghorbani\u00a0S, Khatami\u00a0A, et al. Comparison of confirmed COVID-19 with SARS and MERS cases\u2014clinical characteristics, laboratory findings, radiographic signs and outcomes: a\u00a0systematic review and meta-analysis. Rev Med Virol. 2020; https:\/\/doi.org\/10.1002\/rmv.2112.","journal-title":"Rev Med Virol"},{"key":"1475_CR33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad\u00a0M, Martin\u00a0JC. Pathological inflammation in patients with COVID-19: a\u00a0key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362.","journal-title":"Nat Rev Immunol"},{"key":"1475_CR34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay\u00a0MZ, Poh\u00a0CM, R\u00e9nia\u00a0L, et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1475_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.19.049254v1","volume-title":"Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells","author":"C Muus","year":"2020","unstructured":"Muus\u00a0C, Luecken\u00a0MD, Eraslan\u00a0G, et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV\u20112 viral entry and highlights inflammatory programs in putative target cells. 2020. https:\/\/doi.org\/10.1101\/2020.04.19.049254v1. bioRxiv 2020.04.19.049254."},{"key":"1475_CR36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/jcm9020538","volume":"9","author":"NM Linton","year":"2020","unstructured":"Linton\u00a0NM, Kobayashi\u00a0T, Yang\u00a0Y, et\u00a0al. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a\u00a0statistical analysis of publicly available case data. J\u00a0Clin Med. 2020;9:538.","journal-title":"J Clin Med"},{"key":"1475_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang\u00a0C, Wang\u00a0Y, Li\u00a0X, et\u00a0al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"1475_CR38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou\u00a0F, Yu\u00a0T, Du\u00a0R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a\u00a0retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"1475_CR39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020201160","author":"HYF Wong","year":"2019","unstructured":"Wong\u00a0HYF, Lam\u00a0HYS, Fong\u00a0AH, et al. Frequency and distribution of chest radiographic findings in COVID-19 positive patients. Radiology. 2019; https:\/\/doi.org\/10.1148\/radiol.2020201160.","journal-title":"Radiology"},{"key":"1475_CR40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi\u00a0H, Han\u00a0X, Jiang\u00a0N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a\u00a0descriptive study. Lancet Infect Dis. 2020;20:425\u201334.","journal-title":"Lancet Infect Dis"},{"key":"1475_CR41","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.21037\/qims-20-564","volume":"10","author":"Z Sun","year":"2020","unstructured":"Sun\u00a0Z, Zhang\u00a0N, Li\u00a0Y, Xu\u00a0X. A systematic review of chest imaging findings in COVID-19. Quant Imaging Med Surg. 2020;10:1058\u201379.","journal-title":"Quant Imaging Med Surg"},{"key":"1475_CR42","doi-asserted-by":"crossref","first-page":"E1753","DOI":"10.3390\/jcm9061753","volume":"9","author":"J Baj","year":"2020","unstructured":"Baj\u00a0J, Karaku\u0142a-Juchnowicz\u00a0H, Teresi\u0144ski\u00a0G, et al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J\u00a0Clin Med. 2020;9:E1753.","journal-title":"J Clin Med"},{"key":"1475_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106024","author":"CC Lai","year":"2020","unstructured":"Lai\u00a0CC, Ko\u00a0WC, Lee\u00a0PI, et al. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020; https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106024.","journal-title":"Int J Antimicrob Agents"},{"key":"1475_CR44","doi-asserted-by":"publisher","first-page":"117839","DOI":"10.1016\/j.lfs.2020.117839","volume":"255","author":"K Renu","year":"2020","unstructured":"Renu\u00a0K, Prasanna\u00a0PL, Valsala Gopalakrishnan\u00a0A. Coronaviruses pathogenesis, comorbidities and multi-organ damage\u2014a\u00a0review. Life Sci. 2020;255:117839. https:\/\/doi.org\/10.1016\/j.lfs.2020.117839.","journal-title":"Life Sci"},{"key":"1475_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09974-2","author":"L Wang","year":"2020","unstructured":"Wang\u00a0L, Shen\u00a0Y, Li\u00a0M, et al. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a\u00a0systematic review and meta-analysis. J\u00a0Neurol. 2020; https:\/\/doi.org\/10.1007\/s00415-020-09974-2.","journal-title":"J Neurol"},{"key":"1475_CR46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijsu.2020.04.001","volume":"77","author":"M Nicola","year":"2020","unstructured":"Nicola\u00a0M, O\u2019Neill\u00a0N, Sohrabi\u00a0C, et al. Evidence based management guideline for the COVID-19 pandemic\u2014review article. Int J Surg. 2020;77:206\u201316.","journal-title":"Int J Surg"},{"key":"1475_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fpubh.2020.00189","volume":"8","author":"P Xie","year":"2020","unstructured":"Xie\u00a0P, Ma\u00a0W, Tang\u00a0H, et al. Severe COVID-19: a\u00a0review of recent progress with a\u00a0look toward the future. Front Public Health. 2020;8:189. https:\/\/doi.org\/10.3389\/fpubh.2020.00189.","journal-title":"Front Public Health"},{"key":"1475_CR48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","volume":"181","author":"MG Netea","year":"2020","unstructured":"Netea\u00a0MG, Giamarellos-Bourboulis\u00a0EJ, Dom\u00ednguez-Andr\u00e9s\u00a0J, et al. Trained immunity: a\u00a0tool for reducing susceptibility to and the severity of SARS-CoV\u20112 infection. Cell. 2020;181:969\u201377.","journal-title":"Cell"},{"key":"1475_CR49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","volume":"20","author":"AM Risitano","year":"2020","unstructured":"Risitano\u00a0AM, Mastellos\u00a0DC, Huber-Lang\u00a0M, et al. Complement as a\u00a0target in COVID-19? Nat Rev Immunol. 2020;20:343\u20134.","journal-title":"Nat Rev Immunol"},{"key":"1475_CR50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao\u00a0X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269\u201370.","journal-title":"Nat Rev Immunol"},{"key":"1475_CR51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fmed.2020.00301","volume":"7","author":"X Feng","year":"2020","unstructured":"Feng\u00a0X, Li\u00a0S, Sun\u00a0Q, et al. Immune-inflammatory parameters in COVID-19 cases: a\u00a0systematic review and meta-analysis. Front Med (Lausanne). 2020;7:301.","journal-title":"Front Med (Lausanne)"},{"key":"1475_CR52","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long\u00a0QX, Liu\u00a0BZ, Deng\u00a0HJ, et al. Antibody responses to SARS-CoV\u20112 in patients with COVID-19. Nat Med. 2020;26:845\u20138.","journal-title":"Nat Med"},{"key":"1475_CR53","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","volume":"507","author":"A Padoan","year":"2020","unstructured":"Padoan\u00a0A, Sciacovelli\u00a0L, Basso\u00a0D, et al. IgA-Ab response to spike glycoprotein of SARS-CoV\u20112 in patients with COVID-19: a\u00a0longitudinal study. Clin Chim Acta. 2020;507:164\u20136.","journal-title":"Clin Chim Acta"},{"key":"1475_CR54","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni\u00a0A, Weiskopf\u00a0D, Ramirez\u00a0SI, et al. Targets of T cell responses to SARS-CoV\u20112 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489\u2013501.","journal-title":"Cell"},{"key":"1475_CR55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","volume":"52","author":"L Ni","year":"2020","unstructured":"Ni\u00a0L, Ye\u00a0F, Cheng\u00a0ML, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971\u20137.","journal-title":"Immunity"},{"key":"1475_CR56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/M20-1301","volume":"172","author":"MP Cheng","year":"2020","unstructured":"Cheng\u00a0MP, Papenburg\u00a0J, Desjardins\u00a0M, et al. Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a\u00a0narrative review. Ann Intern Med. 2020;172:726\u201334.","journal-title":"Ann Intern Med"},{"key":"1475_CR57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jclinpath-2020-206685","volume":"73","author":"M Venter","year":"2020","unstructured":"Venter\u00a0M, Richter\u00a0K. Towards effective diagnostic assays for COVID-19: a\u00a0review. J\u00a0Clin Pathol. 2020;73:370\u20137.","journal-title":"J Clin Pathol"},{"key":"1475_CR58","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.3390\/biomedicines8050109","volume":"8","author":"K Lundstrom","year":"2020","unstructured":"Lundstrom\u00a0K. Coronavirus pandemic-therapy and vaccines. Biomedicines. 2020;8:E109.","journal-title":"Biomedicines"},{"key":"1475_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-020-00300-x","volume":"9","author":"E Padron-Regalado","year":"2020","unstructured":"Padron-Regalado\u00a0E. Vaccines for SARS-CoV-2: lessons from other coronavirus strains. Infect Dis Ther. 2020;9:1\u201320.","journal-title":"Infect Dis Ther"},{"key":"1475_CR60","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms21072657","volume":"21","author":"YF Tu","year":"2020","unstructured":"Tu\u00a0YF, Chien\u00a0CS, Yarmishyn\u00a0AA, et al. A review of SARS-CoV\u20112 and the ongoing clinical trials. Int J Mol Sci. 2020;21:2657.","journal-title":"Int J Mol Sci"},{"key":"1475_CR61","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/jvi.64.3.1407-1409.1990","volume":"64","author":"H Vennema","year":"1990","unstructured":"Vennema\u00a0H, de Groot\u00a0RJ, Harbour\u00a0DA, et\u00a0al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J\u00a0Virol. 1990;64:1407\u20139.","journal-title":"J Virol"},{"key":"1475_CR62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chom.2020.04.021","volume":"27","author":"MS Diamond","year":"2020","unstructured":"Diamond\u00a0MS, Pierson\u00a0TC. The challenges of vaccine development against a\u00a0new virus during a\u00a0pandemic. Cell Host Microbe. 2020;27:699\u2013703.","journal-title":"Cell Host Microbe"},{"key":"1475_CR63","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fmicb.2020.00658","volume":"11","author":"LV Tse","year":"2020","unstructured":"Tse\u00a0LV, Meganck\u00a0RM, Graham\u00a0RL, Baric\u00a0RS. The current and future state of vaccines, antivirals and gene therapies against emerging coronaviruses. Front Microbiol. 2020;11:658.","journal-title":"Front Microbiol"},{"key":"1475_CR64","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.14.20065771","volume-title":"A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease","author":"AT Huang","year":"2020","unstructured":"Huang\u00a0AT, Garcia-Carreras\u00a0B, Hitchings\u00a0MDT, et al. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. 2020. https:\/\/doi.org\/10.1101\/2020.04.14.20065771. medRxiv 2020.04.14.20065771."},{"key":"1475_CR65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","volume":"508","author":"M Lotfi","year":"2020","unstructured":"Lotfi\u00a0M, Hamblin\u00a0MR, Rezaei\u00a0N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254\u201366.","journal-title":"Clin Chim Acta"},{"key":"1475_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-020-01439-5","author":"AAF de Vries","year":"2020","unstructured":"de Vries\u00a0AAF. Renin-angiotensin system inhibition in COVID-19 patients. Neth Heart\u00a0J. 2020; https:\/\/doi.org\/10.1007\/s12471-020-01439-5.","journal-title":"Neth Heart J"},{"key":"1475_CR67","doi-asserted-by":"crossref","first-page":"117775","DOI":"10.1016\/j.lfs.2020.117775","volume":"254","author":"VM Patil","year":"2020","unstructured":"Patil\u00a0VM, Singhal\u00a0S, Masand\u00a0N. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: efficacy, safety and clinical trials. Life Sci. 2020;254:117775.","journal-title":"Life Sci"},{"key":"1475_CR68","doi-asserted-by":"crossref","first-page":"104904","DOI":"10.1016\/j.phrs.2020.104904","volume":"158","author":"E Quiros Roldan","year":"2020","unstructured":"Quiros Roldan\u00a0E, Biasiotto\u00a0G, et al. The possible mechanisms of action of 4\u2011aminoquinolines (chloroquine\/hydroxychloroquine) against SARS-CoV\u20112 infection (COVID-19): a\u00a0role for iron homeostasis? Pharmacol Res. 2020;158:104904.","journal-title":"Pharmacol Res"},{"key":"1475_CR69","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","volume":"130","author":"EM Bloch","year":"2020","unstructured":"Bloch\u00a0EM, Shoham\u00a0S, Casadevall\u00a0A, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J\u00a0Clin Invest. 2020;130:2757\u201365.","journal-title":"J Clin Invest"},{"key":"1475_CR70","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee\u00a0AJ, Ashkar\u00a0AA. The dual nature of type I and type II interferons. Front Immunol. 2018;9:2061.","journal-title":"Front Immunol"},{"key":"1475_CR71","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/bs.aivir.2016.08.006","volume":"96","author":"E Kindler","year":"2016","unstructured":"Kindler\u00a0E, Thiel\u00a0V, Weber\u00a0F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv Virus Res. 2016;96:219\u201343.","journal-title":"Adv Virus Res"},{"key":"1475_CR72","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler\u00a0CGK, Allon\u00a0SJ, Nyquist\u00a0SK, et al. SARS-CoV\u20112 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016\u201335.","journal-title":"Cell"},{"key":"1475_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/all.14364","author":"AK Azkur","year":"2020","unstructured":"Azkur\u00a0AK, Akdis\u00a0M, Azkur\u00a0D, et al. Immune response to SARS-CoV\u20112 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020; https:\/\/doi.org\/10.1111\/all.14364.","journal-title":"Allergy"},{"key":"1475_CR74","doi-asserted-by":"crossref","first-page":"102569","DOI":"10.1016\/j.autrev.2020.102569","volume":"19","author":"J Alijotas-Reig","year":"2020","unstructured":"Alijotas-Reig\u00a0J, Esteve-Valverde\u00a0E, Belizna\u00a0C, et al. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: a\u00a0comprehensive review. Autoimmun Rev. 2020;19:102569.","journal-title":"Autoimmun Rev"},{"key":"1475_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.06.012","author":"C Solinas","year":"2020","unstructured":"Solinas\u00a0C, Perra\u00a0L, Aiello\u00a0M, et al. A critical evaluation of glucocorticoids in the management of severe COVID-19. Cytokine Growth Factor Rev. 2020; https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.012.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1475_CR76","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.11.20096347","volume-title":"The effects of ARBs, ACEIs and statins on clinical outcomes of 1 COVID-19 infection among nursing home residents","author":"A De Spiegeleer","year":"2020","unstructured":"De Spiegeleer\u00a0A, Bronselaer\u00a0A, Teo\u00a0JT, et al. The effects of ARBs, ACEIs and statins on clinical outcomes of 1 COVID-19 infection among nursing home residents. 2020. https:\/\/doi.org\/10.1101\/2020.05.11.20096347. medRxiv 2020.05.11.20096347."},{"key":"1475_CR77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok\u00a0FA, Kruip\u00a0MJHA, van der Meer\u00a0NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148\u201350.","journal-title":"Thromb Res"},{"key":"1475_CR78","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang\u00a0N, Li\u00a0D, Wang\u00a0X, Sun\u00a0Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J\u00a0Thromb Haemost. 2020;18:844\u20137.","journal-title":"J Thromb Haemost"},{"key":"1475_CR79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","volume":"50","author":"RC Becker","year":"2020","unstructured":"Becker\u00a0RC. COVID-19 update: COVID-19-associated coagulopathy. J\u00a0Thromb Thrombolysis. 2020;50:54\u201367.","journal-title":"J Thromb Thrombolysis"},{"key":"1475_CR80","doi-asserted-by":"publisher","DOI":"10.1159\/000508233","author":"S Tal","year":"2020","unstructured":"Tal\u00a0S, Spectre\u00a0G, Kornowski\u00a0R, Perl\u00a0L. Venous thromboembolism complicated with COVID-19: what do we know so far? Acta Haematol. 2020; https:\/\/doi.org\/10.1159\/000508233.","journal-title":"Acta Haematol"},{"key":"1475_CR81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"LA Teuwen","year":"2020","unstructured":"Teuwen\u00a0LA, Geldhof\u00a0V, Pasut\u00a0A, Carmeliet\u00a0P. COVID-19: the vasculature. Nat Rev Immunol. 2020;20:389\u201391.","journal-title":"Nat Rev Immunol"},{"key":"1475_CR82","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang\u00a0N, Bai\u00a0H, Chen\u00a0X, et\u00a0al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J\u00a0Thromb Haemost. 2020;18:1094\u20139.","journal-title":"J Thromb Haemost"},{"key":"1475_CR83","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli\u00a0B, Madhavan\u00a0MV, Jimenez\u00a0D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up JACC state-of-the-art review. J\u00a0Am Coll Cardiol. 2020;75:2950\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"1475_CR84","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","volume":"126","author":"A Akhmerov","year":"2020","unstructured":"Akhmerov\u00a0A, Marb\u00e1n\u00a0E. COVID-19 and the heart. Circ Res. 2020;126:1443\u201355.","journal-title":"Circ Res"},{"key":"1475_CR85","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehaa408","volume":"41","author":"S Shi","year":"2020","unstructured":"Shi\u00a0S, Qin\u00a0M, Cai\u00a0Y, et\u00a0al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart\u00a0J. 2020;41:2070\u20139.","journal-title":"Eur Heart J"},{"key":"1475_CR86","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cardfail.2020.05.006","volume":"26","author":"NS Hendren","year":"2020","unstructured":"Hendren\u00a0NS, Grodin\u00a0JL, Drazner\u00a0MH. Unique patterns of cardiovascular involvement in coronavirus disease-2019. J\u00a0Card Fail. 2020;26:466\u20139.","journal-title":"J Card Fail"},{"key":"1475_CR87","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","volume":"141","author":"NS Hendren","year":"2020","unstructured":"Hendren\u00a0NS, Drazner\u00a0MH, Bozkurt\u00a0B, et al. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141:1903\u201314.","journal-title":"Circulation"},{"key":"1475_CR88","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0950","author":"S Shi","year":"2020","unstructured":"Shi\u00a0S, Qin\u00a0M, Shen\u00a0B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA. 2020; https:\/\/doi.org\/10.1001\/jamacardio.2020.0950.","journal-title":"JAMA"},{"key":"1475_CR89","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1017","author":"T Guo","year":"2020","unstructured":"Guo\u00a0T, Fan\u00a0Y, Chen\u00a0M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA. 2020; https:\/\/doi.org\/10.1001\/jamacardio.2020.1017.","journal-title":"JAMA"},{"key":"1475_CR90","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","volume":"75","author":"E Driggin","year":"2020","unstructured":"Driggin\u00a0E, Madhavan\u00a0MV, Bikdeli\u00a0B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J\u00a0Am Coll Cardiol. 2020;75:2352\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"1475_CR91","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa106","author":"TJ Guzik","year":"2020","unstructured":"Guzik\u00a0TJ, Mohiddin\u00a0SA, Dimarco\u00a0A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020; https:\/\/doi.org\/10.1093\/cvr\/cvaa106.","journal-title":"Cardiovasc Res"},{"key":"1475_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2020.05.101","author":"BP Dhakal","year":"2020","unstructured":"Dhakal\u00a0BP, Sweitzer\u00a0NK, Indik\u00a0JH, Acharya\u00a0D, William\u00a0P. SARS-CoV\u20112 infection and cardiovascular disease: COVID-19 heart. Heart Lung Circ. 2020; https:\/\/doi.org\/10.1016\/j.hlc.2020.05.101.","journal-title":"Heart Lung Circ"},{"key":"1475_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2020.05.004","author":"S Ganatra","year":"2020","unstructured":"Ganatra\u00a0S, Dani\u00a0SS, Shah\u00a0S, et al. Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic. Trends Cardiovasc Med. 2020; https:\/\/doi.org\/10.1016\/j.tcm.2020.05.004.","journal-title":"Trends Cardiovasc Med"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-020-01475-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T23:50:25Z","timestamp":1626306625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-020-01475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":93,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1007\/s12471-020-01475-1","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"15 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.A.F.\u00a0de Vries declares that he has no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}